ESR1 and transient myeloproliferative syndrome: Moreover, HBXIP inhibits the expression of ER-α by HOXB13, leading to TAM off-target, and acts as a co-activator of HOXB13 to stimulate IL-6 transcription, resulting in the acceleration of proliferation.